|
- JAI started Genex, the fourth biotech company in 1977 which was bought by Enzon, Inc.
- In 1980 we started Cytogen which was the one of the first monoclonal antibody companies with a focus on delivery of cytotoxic agents to kill tumors and delivery of radio isotopes to image tumors. Cytogen was bought by EUSA Pharma in 2008.
- In 1981 we started Sepracor whose focus was the separation of racemic mixtures into the single isomers and the active metabolites. The initial investors in Sepracor were Venrock, NEA and British Rothschild (now Domain). Sepracor was acquired by Daimippon Sumitomo in 2009.
- In 1983 we founded i-STAT with Jack Whitehead (Technicon and the Whitehead Institute) as the key investor. I-STAT focused on the "pocket doc", a device about the size of two packs of cigarettes that you could get key analytes, blood gases, etc... The company went public, and was sold to Abbott in 2004.
- In 1985 we started Envirogen, one of the early companies working on bio degradation/bio remediation. Their focus was on PCB's and MTB. The company was sold to Shaw Environmental in 2003.
- Immunicon was financed in 1985 focused on ferrite particle and magetics for rare cell separation focused on cancer and was acquired by J&J in 2008.
|
